Information Provided By: 
Fly News Breaks for September 17, 2018
CI, ESRX
Sep 17, 2018 | 20:24 EDT
Credit Suisse analyst Erin Wright downgraded Express Scripts (ESRX) to Neutral from Outperform but raised her price target to $96.90 from $90 after the Antitrust Division of the United States Department of Justice has cleared its pending merger with Cigna (CI).
News For ESRX;CI From the Last 2 Days
There are no results for your query ESRX;CI
